Home blood test monitoring for cancer patients on chemotherapy
Part of Cancer clinical trials.
This study tests whether cancer patients can do their own blood counts at home using a finger-prick test. It will help see if home monitoring is a good option for people receiving chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a cancer diagnosis (ICD-10 codes C00-C97)
- You are receiving chemotherapy as an outpatient and you started within the last 4 weeks
- Your chemotherapy is expected to continue for at least 12 more weeks
- You are able to use a small device to get a drop of blood from your finger
- You do not have a bleeding disorder or circulation problems that would make it hard to get enough blood
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study collects and stores blood and protein samples from people with cancer to help future research. You may be asked to return for follow-up appointments so the researchers can link your samples to health outcomes.
This study looks for markers of cancer in your blood. It may help doctors learn more about your tumor and how to treat it.
This study tests an easier way to measure the amount of cancer medicine in your blood using a simple finger prick instead of a standard blood draw. If you are taking one of the listed oral or IV cancer drugs, you may be able to participate.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.